Atlas Trials

A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA

Clinical trial NCT05223166 · COMPLETED

Trial details

NCT number
NCT05223166
Sponsor
Citrine Medicine Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Excessive Daytime Sleepiness
Start date
2022-04-12
Primary completion
2023-07-18
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.